Basic/Clinical Science Session
Molecular-Driven Management of Lupus Nephritis, One Cell at a Time
October 26, 2024 | 02:00 PM - 04:00 PM
Location: Room 6A, Convention Center
Session Description
Cellular resolved disease modeling is revealing unprecedented insight into lupus nephritis immunopathobiology. Patients can be stratified based on their immune-cell phenotype in kidney biopsy tissue, circulating immune-cell population, and immune mediators. Insights from studies allow linkage of immune-cell phenotypes with treatment responses, moving toward the goal of personalizing treatment choices and targeted treatment trials in lupus nephritis.
Learning Objective(s)
- Summarize immune-cell pathobiology in lupus nephritis
- Define subtypes of lupus in mechanistic molecular terms
- Identify strategies to bring targeted treatments to patients with various lupus subtypes
Learning Pathway(s)
- Glomerular Diseases
- Pathology
Moderators
Presentations
- Catching Lupus Nephritis Molecular Program In Flagranti: Lessons Learned from Accelerating Medicines Partnership Biopsies
02:00 PM - 02:30 PM
- Lupus Nephritis Activity and Treatment Response in Peripheral Blood Lymphocytes: Deep Immune-Cell Profiling
02:30 PM - 03:00 PM
- Urine Proteomics and Liquid Kidney Biopsy in Systemic Lupus Erythematosus
03:00 PM - 03:30 PM
- Developing Targeted Treatments for Lupus Nephritis: Time for Precision Trials
03:30 PM - 04:00 PM